David Olson

Welcome to our CaringBridge website. We are using it to keep family and friends updated in one place. We appreciate your support and words of hope and encouragement. Thank you for visiting.
David is getting treatment at Northwestern Hospital, NWH, with Dr. Aparna Kalyan and her team. His metastatic pancreatic adenocarcinoma qualifies him for a clinical research study--a 5-drug combination. These are:
-5-Fluorouracil
-Bevacizumab
-Leucovorin
-Oxaliplatin
-nab-Paclitaxel


These will be administered in 28-day cycles followed by assessments. There are a lot of details about how and when David gets these drugs. There is more info about this clinical trial at http://www.ClinicalTrials.gov.  Here is the Sponsor/Study Title:
Celgene Corporation/ "An open-label, multicenter, sungle-arm, Phase 1/2 study of metronomic 5-fluorouracil in combination with nab-paclitaxel, bevacizumab, leucovorin, and oxaliplatin in patients with metastatic pancreatic adenocarcinoma."


We will keep you posted.